Discover Tenders by Cards Containing Integrated Circuits Sector

Find the most relevant tenders for Cards Containing Integrated Circuits. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Cards Containing Integrated Circuits tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Cards Containing Integrated Circuits tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Medicines Containing The Active Ingredient Telmisartan Atc C09Ca07

Deadline: 31 Jul 2026

Germany

Ref. No.: 7790984

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Medicines Containing The Active Ingredient Telmisartan Atc C09Ca07

Deadline: 31 Jul 2026

Germany

Ref. No.: 7790983

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Lopinavir And Ritonavir Atc Code J05Ar10

Deadline: 28 Jul 2026

Germany

Ref. No.: 7766088

EMD:Ref Document

Bid Value: Ref Document

257 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Telmisartan Atc Code C09Ca07

Deadline: 28 Jul 2026

Germany

Ref. No.: 7747295

EMD:Ref Document

Bid Value: Ref Document

257 Days Left

Homotopy Theory Of Algebraic Varieties And Wild Ramification

Deadline: 31 May 2026

Poland

Ref. No.: 7739787

EMD:Ref Document

Bid Value: Ref Document

199 Days Left

Regulation Of Nk Cell Function

Deadline: 30 Nov 2025

Germany

Ref. No.: 7739702

EMD:Ref Document

Bid Value: Ref Document

17 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Interferon Beta 1A L03Ab07 Subcutaneous Injection Within The Framework Of A So Call

Deadline: 31 Jul 2026

Germany

Ref. No.: 7708163

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Naproxen M01Ae02 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7702625

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Rasagiline N04Bd02 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7697176

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Miglustat A16Ax06 As Part Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7696670

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Lacosamide N03Ax18 Excluding Film Coated Tablets Within The Framework Of A So Call

Deadline: 31 Jul 2026

Germany

Ref. No.: 7693028

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Febuxostat M04Aa03 As Part Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7690242

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Irbesartan And Hydrochlorothiazide C09Da24 Within The Framework Of A So Called Open

Deadline: 31 Jul 2026

Germany

Ref. No.: 7682368

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Timolol And Latanoprost S01Ed61 Within The Framework Of A So Called Open House Mod

Deadline: 31 Jul 2026

Germany

Ref. No.: 7681822

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Silodosin G04Ca04 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7680910

EMD:Ref Document

Bid Value: Ref Document

260 Days Left

Showing 40381 to 40395 of 40762 results

‹
1
2
...
2690
2691
2692
2693
2694
2695
2696
...
2717
2718
›

Discover Tenders by Cards Containing Integrated Circuits Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Cards Containing Integrated Circuits Sector

Filter Your Search

FREE Trial plan for all new users!